ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,022, issued on Sept. 22, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Binding molecules for the treatment of cancer" was invented by Juan Manuel Garcia-Martinez (Vienna), Stephan Glaser (Vienna), Gale Lee Hansen (Sandy Hook, Conn.), Srinath Kasturirangan (Brookfield, Conn.), Klaus-Peter Kuenkele (Voesendorf, Austria), Vladimir H. Voynov (Danbury, Conn.), Andreas Wernitznig (Vienna) and Chao Zheng (Briarcliff Manor, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel binding molecules. The invention specifically relates to binding molecules that bind to TNF-related apo...